Clinical spectrum of mitochondrial diseases

被引:48
作者
Fadic, R
Johns, DR
机构
[1] BETH ISRAEL HOSP, DEPT NEUROL, DIV NEUROMUSCULAR DIS, BOSTON, MA 02215 USA
[2] HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT OPHTHALMOL, BOSTON, MA 02115 USA
关键词
mitochondrial diseases; myopathies; multisystem disorders; genetic disease; DNA mutations; mitochondrial DNA;
D O I
10.1055/s-2008-1040954
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mitochondrial diseases include myopathies and multisystem disorders. They are characterized by morphologic and biochemical abnormalities of mitochondria. Their genetic characteristics-maternal inheritance, heteroplasmy, mitotic segregation, and threshold effect-are unique. The clinical phenotypes are considerably heterogeneous, but the clinical presentation in many cases is characteristic or suggestive. We review the clinical features of the most prevalent mitochondrial encephalomyopathy syndromes, their molecular genetic basis, isolated clinical symptoms, and uncommon presentations. Molecular genetic diagnosis is available for the common syndromes and has revolutionized their diagnosis. Future therapeutic advances, based on the precise genetic etiology, are anticipated. Mitochondrial dysfunction may be a more frequent pathogenetic mechanism than the prevalence of the classic mitochondrial syndromes would indicate, as there is an association between the accumulation of mitochondrial DNA mutations in postmitotic tissues and neurologic and systemic degenerative diseases.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 40 条
  • [1] AUSTIN SG, 1994, NEUROLOGY, V44, pA403
  • [2] AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES
    BEAL, MF
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (03) : 357 - 366
  • [3] UBIDECARENONE IN THE TREATMENT OF MITOCHONDRIAL MYOPATHIES - A MULTICENTER DOUBLE-BLIND TRIAL
    BRESOLIN, N
    DORIGUZZI, C
    PONZETTO, C
    ANGELINI, C
    MORONI, I
    CASTELLI, E
    COSSUTTA, E
    BINDA, A
    GALLANTI, A
    GABELLINI, S
    PICCOLO, G
    MARTINUZZI, A
    CIAFALONI, E
    ARNAUDO, E
    LICIARDELLO, L
    CARENZI, A
    SCARLATO, G
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 100 (1-2) : 70 - 78
  • [4] SHORT-TERM DICHLOROACETATE TREATMENT IMPROVES INDEXES OF CEREBRAL METABOLISM IN PATIENTS WITH MITOCHONDRIAL DISORDERS
    DESTEFANO, N
    MATTHEWS, PM
    FORD, B
    GENGE, A
    KARPATI, G
    ARNOLD, DL
    [J]. NEUROLOGY, 1995, 45 (06) : 1193 - 1198
  • [5] MITOCHONDRIAL ENCEPHALOMYOPATHIES
    DIMAURO, S
    MORAES, CT
    [J]. ARCHIVES OF NEUROLOGY, 1993, 50 (11) : 1197 - 1208
  • [6] FADIC R, IN PRESS NEURODEGENE
  • [7] A NEW MTDNA MUTATION ASSOCIATED WITH MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC-ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
    GOTO, Y
    NONAKA, I
    HORAI, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1097 (03) : 238 - 240
  • [8] A MUTATION IN THE TRANSFER RNALEU(UUR) GENE ASSOCIATED WITH THE MELAS SUBGROUP OF MITOCHONDRIAL ENCEPHALOMYOPATHIES
    GOTO, Y
    NONAKA, I
    HORAI, S
    [J]. NATURE, 1990, 348 (6302) : 651 - 653
  • [9] DELETIONS OF MUSCLE MITOCHONDRIAL-DNA IN PATIENTS WITH MITOCHONDRIAL MYOPATHIES
    HOLT, IJ
    HARDING, AE
    MORGANHUGHES, JA
    [J]. NATURE, 1988, 331 (6158) : 717 - 719
  • [10] MITOCHONDRIAL MYOPATHIES - CLINICAL AND BIOCHEMICAL FEATURES OF 30 PATIENTS WITH MAJOR DELETIONS OF MUSCLE MITOCHONDRIAL-DNA
    HOLT, IJ
    HARDING, AE
    COOPER, JM
    SCHAPIRA, AHV
    TOSCANO, A
    CLARK, JB
    MORGANHUGHES, JA
    [J]. ANNALS OF NEUROLOGY, 1989, 26 (06) : 699 - 708